Strata Critical MedicalSRTA

Key highlights

• Revenue and earnings outlook raised: Management raised its full year 2026 revenue forecast to a range of $285 million to $295 million, up from the previous $275 million ceiling, and expects adjusted earnings to reach $33 million to $35 million. These higher targets show the company is growing faster than it first thought after buying several smaller medical service businesses.
• Clinical services driving growth: Revenue from the clinical division, which provides surgical and medical staffing, rose 22.6% to $24.3 million compared to the previous three months. This growth is important because clinical services carry higher profit margins than the older transportation business, helping the company become more profitable as it shifts its focus.
• Acquisition strategy accelerating: The company completed three separate acquisitions during the quarter, including Ohio Valley Perfusion and Louisville Perfusion Services, to expand its local medical teams. These deals added more than $6 million in projected yearly earnings and help the company save money by keeping its staff closer to the hospitals they serve.
• Logistics margins facing pressure: Gross margins for the logistics division, which is the money left after paying for the direct costs of transport, fell to 18.4% from 20.0% a year ago. The company blamed higher fuel costs and a shift in customer mix, where shorter trip distances resulted in lower overall payments per flight.
• Brand integration costs hit profits: The company reported a net loss from continuing operations of $10.5 million, which was significantly higher than the $3.4 million loss from a year ago. A major reason for this was $5.0 million in one time costs to retire the old Blade brand and fully move the business over to the new Strata name.

Our take: This was a strong quarter that shows the company is successfully transforming from a flight broker into a specialized medical service provider. The significant raise in full year guidance suggests the recent acquisitions are integrating well and generating more profit than expected. While high one time rebranding costs masked the bottom line, the core business is becoming much healthier.